Impact of Acute Exercise on Vascular Insulin Sensitivity in Metabolic Syndrome

Obesity Clinical Trial

Official title:

Impact of Acute Exercise on Vascular Insulin Sensitivity in Metabolic Syndrome

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03894527
• Other study ID #: 19060
• Status: Recruiting
• Phase: N/A
• Start date: February 18, 2019
• Est. completion date: January 31, 2020

Study information

• Verified date: March 2019
• Source: University of Virginia
• Contact: Emily Heiston, M.Ed.
• Phone: 434-243-8677
• Email: emh5bh[@]virginia.edu
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Obesity is an independent risk factor for type 2 diabetes and cardiovascular disease. The increased prevalence of obesity worldwide is a major concern among the scientific and medical communities. Insulin resistance is a common factor associated with obesity, metabolic syndrome, hypertension, and type 2 diabetes. Individuals affected by these conditions often experience endothelial dysfunction as well. Insulin resistance provides a key link between metabolic syndrome risk factors and vascular disease. Development of strategies aimed at preventing vascular dysfunction and future disease caused by metabolic disturbances is needed. Although the relationship between obesity and various diseases is well known, the acute effects of insulin on vascular function in obese individuals have yet to be fully determined. Additionally, the effects of acute exercise on insulin-stimulated endothelial function are unknown. Exercise may be an effective and potent treatment that protects against endothelial dysfunction, insulin resistance, and future cardiometabolic disease commonly present with obesity. However, less attention has been placed on vascular insulin sensitivity. The purpose of this study is to test the hypothesis that a single bout of exercise increases insulin-stimulated blood flow at the macro- and micro-vasculature level in obese individuals with metabolic syndrome to similar levels as healthy obese control. Our laboratory has available non-invasive methods to quantify vascular function and the gold-standard technique for assessing insulin sensitivity (euglycemic-hyperinsulinemic clamp). The investigators will assess vascular function (flow-mediated dilation, post-ischemic flow velocity and contrast-enhanced ultrasound) as well as arterial stiffness (augmentation index and pulse wave velocity) before and at the end of the clamp protocol performed the morning following a bout of exercise and a control (no-exercise) condition in 1) metabolic syndrome and 2) obese adults. If our hypothesis is sustained, it will suggest that a key role of the vasculature exists in regulating insulin following exercise and will provide insight into the link between the vasculature, obesity, metabolic syndrome and cardiovascular disease and may confer decreased risk for cardiometabolic disease.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 16
• Est. completion date: January 31, 2020
• Est. primary completion date: September 30, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 40 Years to 70 Years

Eligibility

Inclusion Criteria:

• Males and females, ages 40-70 years

• Never diagnosed with type 2 diabetes and/or cardiovascular disease

• Not currently engaged in > 60 min/wk of exercise

• Inclusion criteria specific to health obese vs. metabolic syndrome potential participants:

• Healthy Obese: (BMI = 30 kg/m2 but = 45 kg/m2) and no other metabolic syndrome risk factors, excluding waist circumference.

• Metabolic Syndrome: (BMI = 30 kg/m2 but = 45 kg/m2) and must meet at least 3 out of 5 National Cholesterol Education Adult Treatment Panel III Metabolic Syndrome Criteria:

Increased waist circumference (=102 cm in men; =88 cm in women) Elevated triglycerides (=150 mg/dl) or currently taking medication (Rx) Reduced HDL-cholesterol (<40mg/dl in men, <50 mg/dl in women) or currently taking medication (Rx) High blood pressure (=130 mmHg systolic or =85mmHg diastolic) or currently taking medication (Rx) Elevated fasting glucose (=100 mg/dl)

Subject may participate if on the following drugs:

• Diuretics, ace-inhibitors and ARBs for treatment of hypertension

• Statins

Exclusion Criteria:

• Morbidly obese patients (BMI >45 kg/m2) and overweight/lean patients (BMI <30 kg/m2).

• Subjects who have not been weight stable (>2kg weight change in past 3 months).

• Currently participating in a regular exercise training program ( >30 min. of physical activity per day, >2 days/week)

• Medication or food supplement that is known to affect insulin sensitivity or endothelial function (TZDs, sulfonylureas, biguanides, alpha-glucosidase inhibitors, phosphodiesterase inhibitors, beta-blockers, alpha-blockers, fibrates, glucocorticoids, fish oil, allopurinol)

• Subjects with abnormal estimated glomerular filtration rate (eGFR).

• Hypertriglyceridemic (>400 mg/dl) subjects.

• Hypertensive (>160/100 mmHg)

• Subjects taking vasoactive medications also known to affect heart rate and rhythm (i.e. Ca++ channel blockers, nitrates, alpha- or beta-blockers).

• Subjects with a history of significant metabolic, cardiac, congestive heart failure, cerebrovascular, hematological, pulmonary, gastrointestinal, liver, renal, or endocrine disease or cancer that in the investigator's opinion would interfere with or alter the outcome measures, or impact subject safety.

• Smoking presently or in the past 1 year.

• HbA1c = 6.5

• Subjects currently taking Metformin or any active weight suppression medication (e.g. phentermine, orlistat, lorcaserin, naltrexone-bupropion in combination, liraglutide, benzphetamine, diethylpropion, phendimetrazine)

• Pregnant (as evidenced by positive pregnancy test) or breastfeeding

• Subjects with contraindications to participation in an exercise program

• Known hypersensitivity to perflutren (contained in Definity)

Related Conditions & MeSH terms

• Insulin Resistance
• Metabolic Syndrome
• Obesity
• Syndrome

Intervention

Behavioral:
• Single Bout of Exercise
An exercise condition, which will be walking at a moderate intensity (~70% VO2peak). Time will vary based upon individual fitness levels to burn ~400kcals (estimated 0.5 - 1hr). Oxygen consumption will be measured during exercise via a metabolic cart to confirm energy expenditure. Participants will then rest following the exercise procedure for 20 minutes. Between 20 and 45 minutes following exercise, oxygen consumption will be measured to understand and capture excess post-exercise oxygen consumption (EPOC). Following this, participants will be provided with a standardize dinner and snack to consume in the AMP lab.
• Control Condition
A control (no-exercise) condition. Participants will report to the AMP lab to rest for the same duration as the exercise bout and consume the standardized dinner and snack.

Locations

Country	Name	City	State
United States	University of Virginia	Charlottesville	Virginia

Sponsors (2)

Lead Sponsor	Collaborator
University of Virginia	American College of Sports Medicine

Country where clinical trial is conducted

United States, 

References & Publications (27)

Barrett EJ, Eggleston EM, Inyard AC, Wang H, Li G, Chai W, Liu Z. The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin action. Diabetologia. 2009 May;52(5):752-64. doi: 10.1007/s00125-009-1313-z. Epub 2009 Mar 13. Review. — View Citation

Barrett EJ, Liu Z. The endothelial cell: an "early responder" in the development of insulin resistance. Rev Endocr Metab Disord. 2013 Mar;14(1):21-7. doi: 10.1007/s11154-012-9232-6. Review. — View Citation

Barrett EJ, Wang H, Upchurch CT, Liu Z. Insulin regulates its own delivery to skeletal muscle by feed-forward actions on the vasculature. Am J Physiol Endocrinol Metab. 2011 Aug;301(2):E252-63. doi: 10.1152/ajpendo.00186.2011. Epub 2011 May 24. Review. — View Citation

Clerk LH, Vincent MA, Jahn LA, Liu Z, Lindner JR, Barrett EJ. Obesity blunts insulin-mediated microvascular recruitment in human forearm muscle. Diabetes. 2006 May;55(5):1436-42. — View Citation

Coggins M, Lindner J, Rattigan S, Jahn L, Fasy E, Kaul S, Barrett E. Physiologic hyperinsulinemia enhances human skeletal muscle perfusion by capillary recruitment. Diabetes. 2001 Dec;50(12):2682-90. — View Citation

Dawson EA, Green DJ, Cable NT, Thijssen DH. Effects of acute exercise on flow-mediated dilatation in healthy humans. J Appl Physiol (1985). 2013 Dec;115(11):1589-98. doi: 10.1152/japplphysiol.00450.2013. Epub 2013 Sep 12. — View Citation

DeFronzo RA, Sherwin RS, Kraemer N. Effect of physical training on insulin action in obesity. Diabetes. 1987 Dec;36(12):1379-85. — View Citation

Goodpaster BH, Sparks LM. Metabolic Flexibility in Health and Disease. Cell Metab. 2017 May 2;25(5):1027-1036. doi: 10.1016/j.cmet.2017.04.015. Review. — View Citation

Hallmark R, Patrie JT, Liu Z, Gaesser GA, Barrett EJ, Weltman A. The effect of exercise intensity on endothelial function in physically inactive lean and obese adults. PLoS One. 2014 Jan 20;9(1):e85450. doi: 10.1371/journal.pone.0085450. eCollection 2014. — View Citation

Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009 May-Jun;2(5-6):231-7. doi: 10.1242/dmm.001180. Review. — View Citation

Hwang MH, Lee S. Insulin resistance: vascular function and exercise. Integr Med Res. 2016 Sep;5(3):198-203. doi: 10.1016/j.imr.2016.06.001. Epub 2016 Jun 9. Review. — View Citation

Inyard AC, Clerk LH, Vincent MA, Barrett EJ. Contraction stimulates nitric oxide independent microvascular recruitment and increases muscle insulin uptake. Diabetes. 2007 Sep;56(9):2194-200. Epub 2007 Jun 11. — View Citation

Jahn LA, Hartline L, Rao N, Logan B, Kim JJ, Aylor K, Gan LM, Westergren HU, Barrett EJ. Insulin Enhances Endothelial Function Throughout the Arterial Tree in Healthy But Not Metabolic Syndrome Subjects. J Clin Endocrinol Metab. 2016 Mar;101(3):1198-206. doi: 10.1210/jc.2015-3293. Epub 2016 Jan 12. — View Citation

Malin SK, del Rincon JP, Huang H, Kirwan JP. Exercise-induced lowering of fetuin-A may increase hepatic insulin sensitivity. Med Sci Sports Exerc. 2014 Nov;46(11):2085-90. doi: 10.1249/MSS.0000000000000338. — View Citation

Malin SK, Rynders CA, Weltman JY, Jackson Roberts L 2nd, Barrett EJ, Weltman A. Endothelial function following glucose ingestion in adults with prediabetes: Role of exercise intensity. Obesity (Silver Spring). 2016 Jul;24(7):1515-21. doi: 10.1002/oby.21522. Epub 2016 May 25. — View Citation

Moore JX. Metabolic Syndrome Prevalence by Race/Ethnicity and Sex in the United States, National Health and Nutrition Examination Survey, 1988-2012 [Internet]. Prev Chronic Dis. 2017 [cited 2018 Jan 12 ];14 available from: https://www.cdc.gov/pcd/issues/2017/16_0287.htm. doi:10.5888/pcd14.160287.

Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia. 2001 Sep;44 Suppl 2:S14-21. — View Citation

Muniyappa R, Yavuz S. Metabolic actions of angiotensin II and insulin: a microvascular endothelial balancing act. Mol Cell Endocrinol. 2013 Sep 25;378(1-2):59-69. doi: 10.1016/j.mce.2012.05.017. Epub 2012 Jun 7. Review. — View Citation

Newsom SA, Everett AC, Hinko A, Horowitz JF. A single session of low-intensity exercise is sufficient to enhance insulin sensitivity into the next day in obese adults. Diabetes Care. 2013 Sep;36(9):2516-22. doi: 10.2337/dc12-2606. Epub 2013 Jun 11. — View Citation

Penedo FJ, Dahn JR. Exercise and well-being: a review of mental and physical health benefits associated with physical activity. Curr Opin Psychiatry. 2005 Mar;18(2):189-93. — View Citation

Reynolds LJ, Credeur DP, Manrique C, Padilla J, Fadel PJ, Thyfault JP. Obesity, type 2 diabetes, and impaired insulin-stimulated blood flow: role of skeletal muscle NO synthase and endothelin-1. J Appl Physiol (1985). 2017 Jan 1;122(1):38-47. doi: 10.1152/japplphysiol.00286.2016. Epub 2016 Oct 27. — View Citation

Roberts CK, Hevener AL, Barnard RJ. Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training. Compr Physiol. 2013 Jan;3(1):1-58. doi: 10.1002/cphy.c110062. Review. — View Citation

Shojaee-Moradie F, Baynes KC, Pentecost C, Bell JD, Thomas EL, Jackson NC, Stolinski M, Whyte M, Lovell D, Bowes SB, Gibney J, Jones RH, Umpleby AM. Exercise training reduces fatty acid availability and improves the insulin sensitivity of glucose metabolism. Diabetologia. 2007 Feb;50(2):404-13. Epub 2006 Dec 6. — View Citation

Sjøberg KA, Frøsig C, Kjøbsted R, Sylow L, Kleinert M, Betik AC, Shaw CS, Kiens B, Wojtaszewski JFP, Rattigan S, Richter EA, McConell GK. Exercise Increases Human Skeletal Muscle Insulin Sensitivity via Coordinated Increases in Microvascular Perfusion and Molecular Signaling. Diabetes. 2017 Jun;66(6):1501-1510. doi: 10.2337/db16-1327. Epub 2017 Mar 14. — View Citation

Tjønna AE, Rognmo Ø, Bye A, Stølen TO, Wisløff U. Time course of endothelial adaptation after acute and chronic exercise in patients with metabolic syndrome. J Strength Cond Res. 2011 Sep;25(9):2552-8. doi: 10.1519/JSC.0b013e3181fb4809. — View Citation

Will PM, Walter JD. Exercise testing: improving performance with a ramped Bruce protocol. Am Heart J. 1999 Dec;138(6 Pt 1):1033-7. — View Citation

Zhao Y, Vanhoutte PM, Leung SW. Vascular nitric oxide: Beyond eNOS. J Pharmacol Sci. 2015 Oct;129(2):83-94. doi: 10.1016/j.jphs.2015.09.002. Epub 2015 Sep 28. Review. — View Citation

* Note: There are 27 references in all — Click here to view all references

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Effect of single bout of exercise on FMD	Flow Mediated Dilation (FMD) as a percentage	Baseline clamp study
Primary	Effect of single bout of exercise on CEU	Contrast Enhanced Ultrasound (CEU) as a percentage	Baseline Clamp Study
Primary	Comparison of insulin stimulated FMD response	Flow mediated dilation as a percentage of fasting values	Through study completion, up to about 4 weeks
Primary	Comparison of insulin stimulated CEU response	Contrast Enhanced Ultrasound (CEU) as a percentage of fasting values	Through study completion, up to about 4 weeks
Secondary	Systemic Arterial stiffness	Augmentation Index as a percentage	Through study completion, up to about 4 weeks
Secondary	Central Arterial Stiffness	Pulse wave velocity in m/s	Through study completion, up to about 4 weeks
Secondary	Metabolic Flexibility	Respiratory gases in fasted and insulin-stimulated states in arbitrary units	Through study completion, up to about 4 weeks
Secondary	Fasting glucose	Comparison of glucose collected at baseline in mg/dl	Through study completion, up to about 4 weeks
Secondary	Fasting insulin	Comparison of insulin collected at baseline in uU/ml	Through study completion, up to about 4 weeks
Secondary	Free Fatty Acids	Comparison of free fatty acids collected at baseline in mEq/L	Through study completion, up to about 4 weeks
Secondary	Adiponectin	Comparison of inflammatory in ng/ml	Through study completion, up to about 4 weeks